Malignant peritoneal mesothelioma: Clinicopathological features, prognostic factors, and survival outcomes

MLA

Aurelio Matamoros, et al. “Malignant Peritoneal Mesothelioma: Clinicopathological Features, Prognostic Factors, and Survival Outcomes.” Journal of Clinical Oncology, vol. 36, Feb. 2018, p. 650. EBSCOhost, https://doi.org/10.1200/jco.2018.36.4_suppl.650.

APA

Aurelio Matamoros, Scott Kopetz, Kanwal Pratap Singh Raghav, Jonathan M. Loree, Melissa W. Taggart, Gauri R. Varadhachary, Meera Patel, Anais Malpica, Richard E. Royal, & Keith Fournier. (2018). Malignant peritoneal mesothelioma: Clinicopathological features, prognostic factors, and survival outcomes. Journal of Clinical Oncology, 36, 650. https://doi.org/10.1200/jco.2018.36.4_suppl.650

Chicago

Aurelio Matamoros, Scott Kopetz, Kanwal Pratap Singh Raghav, Jonathan M. Loree, Melissa W. Taggart, Gauri R. Varadhachary, Meera Patel, Anais Malpica, Richard E. Royal, and Keith Fournier. 2018. “Malignant Peritoneal Mesothelioma: Clinicopathological Features, Prognostic Factors, and Survival Outcomes.” Journal of Clinical Oncology 36 (February): 650. doi:10.1200/jco.2018.36.4_suppl.650.